Customer Feedback
Customers consistently mention checking the label before ordering and noticing gradual digestive and focus changes.
The main criticisms are undisclosed per-serving dosing and market confusion from multiple sellers using the same product name.
What customers consistently mention
People check the label before ordering. Several reviewers specifically mention comparing the ingredient list on the physical bottle against what this site described before completing their purchase — exactly the right instinct given how many IQHoney variants exist.
Digestive changes are the most reported early effect. Several reviewers mention noticing digestive regularity changes before any cognitive effect, consistent with the fiber-forward formula.
Results are gradual. The most credible feedback describes subtle changes over several weeks rather than an immediate shift.
Three customer accounts

“Fits easily into my morning routine. Took a few weeks of consistent use before I noticed anything, but I do feel a bit steadier through the afternoon.”

“Simple one-a-day routine, no stimulant jitters. My digestion actually feels more regular too, which I did not expect going in.”

“Double-checked the label against what the site described before ordering, which matched. Modest but real change in afternoon focus after about a month.”
The common criticisms
Formula confusion across sellers is a genuine, recurring complaint. Several third-party reviews note that different IQHoney sites list entirely different ingredients, which understandably frustrates buyers trying to compare information before ordering.
Per-serving amounts are not disclosed. A legitimate complaint shared across most of this product category.
Some advertisements for similarly named products use fabricated celebrity endorsements. We do not repeat those claims anywhere on this site.
An honest overall assessment
This IQHoney formula's standout feature is a narrower, more focused ingredient list than most nootropic competitors, with Spermidine offering genuinely interesting research in the cellular-maintenance space.
Its main limitations are undisclosed per-serving dosing and the broader market confusion caused by multiple sellers using the same product name. What it is not, under any framing, is a treatment for dementia or Alzheimer's — that remains a medical question for your doctor.
